InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by BERRY DAVID A, Director. Director active across 1 companies, notably Omega Therapeutics, Inc.. In total, 2 reports have been logged. Total volume traded: €1.5m. The latest transaction was disclosed on 3 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€760,26753,082 shares@ €14.3225100.0% of flow
Common Stock
SEC:0000899243-21-031303·
Ideal exit: 30 Apr 2022 (T+270)
€760,26753,082 shares@ €14.322550.0% of flow
Common Stock
SEC:0000899243-21-031303:0·
Ideal exit: 30 Apr 2022 (T+270)
2 of 2 declarations
About BERRY DAVID A
David A. Berry is a Board Member of Omega Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide valuable advice to the board. He is committed to supporting the objectives of Omega Therapeutics.
